Research and publications evidence for the Portfolio Pathway: what counts, what does not, and how to present it.

Is research mandatory? The honest answer

The short version: for the large majority of Portfolio Pathway applicants, you do not need a research record to be approved. The General Medical Council (GMC) Portfolio Pathway asks you to demonstrate the knowledge, skills and experience of a UK consultant in your specialty. That demonstration rests on clinical evidence: case logs, workplace-based assessments, audit and quality improvement, multi-source feedback, teaching, and structured reports from senior colleagues. Research sits alongside those as one strand among several, and for most specialties it is desirable rather than required.

This matters because the misconception cuts both ways. Some doctors with strong clinical evidence delay applying for years while they chase a publication they do not actually need. Others assume that because they have three papers, the research box is ticked and the rest of the portfolio can be thin. Both are wrong. The portfolio is assessed as a whole against your specialty's Specialty Specific Guidance (SSG), and the SSG is where the real answer for your specialty lives.

So the first practical step is not to write a paper. It is to read your SSG and find the section on research, academic activity, or scholarship, and see exactly how your college frames it. Some SSGs list research as one of several acceptable forms of evidence for a particular capability. Others mention it only as supporting context. None of the clinical specialties on the standard pathway require you to be a published researcher to reach the Specialist Register. If you read a requirement for high-impact publications and national standing, you are almost certainly reading guidance for the academic route, which is a different application entirely.

Two different routes, and why people confuse them

Most of the anxiety about research comes from mixing up two separate things. The standard Portfolio Pathway and the academic or research route are different applications with different bars. Reading the wrong one is the single most common reason capable doctors talk themselves out of applying.

The academic or research route exists for a reason: there are doctors whose specialist standing genuinely rests on a body of internationally recognised research rather than on a conventional clinical job plan. For them, the GMC guidance is explicit that the work must have been published in high-impact, peer-reviewed journals, assessed by external reviewers in a position to give an expert opinion, with the level of peer review matching the scale of the research. That is a high bar, and it is meant to be.

If that does not describe you, it is not the route you want, and you should stop measuring your research against it. The honest message for the senior SAS doctor, the non-substantive consultant, and most internationally trained applicants is the same: you are almost certainly using the standard pathway, where research is one helpful strand and the clinical evidence does the heavy lifting. If you are unsure which applies to you, the complete guide to the Portfolio Pathway and your SSG together will settle it.

What counts as research and publications evidence

Research and publications evidence is broader than peer-reviewed original research, and that breadth works in your favour. The point of the evidence is to show that you engage critically with the literature, contribute to knowledge or its dissemination, and apply evidence to practice. Plenty of activity short of a randomised controlled trial demonstrates exactly that.

Two practical points sit underneath that table. First, dissemination counts, not just original discovery. A clear case report that changed how your department manages a presentation, presented at a regional meeting and written up, is honest, real, specialty-relevant evidence. Second, the act of appraising the literature is itself worth evidencing. Running a journal club, completing formal critical appraisal training, or contributing to a guideline all show you can read research and translate it into practice, which is exactly the capability the four GMC domains care about.

Research, audit, service evaluation and QI: do not blur the line

The fastest way to lose credibility is to call something research that is not. Senior doctors do a great deal of audit, service evaluation and quality improvement, and all of it is valuable portfolio evidence in its own right. It only becomes a problem when it is dressed up as research it never was. Assessors know the difference instantly, and the relabelling makes them read the rest of your claims more sceptically.

The Health Research Authority (HRA) draws this line for a living. Its principle is straightforward: research seeks new, generalisable knowledge; audit and service evaluation measure or describe existing practice. Audit, service evaluation and quality improvement do not normally need HRA approval or research ethics review, but they do need registering with your trust. Research carried out in the NHS in England usually needs HRA approval and, where applicable, a research ethics committee opinion. If a project genuinely sits on the boundary, the HRA's "Is my study research?" decision tool gives a definitive answer worth saving.

For your portfolio, the implication is simple and freeing. You do not need to inflate anything. A closed audit cycle is strong evidence presented as audit, and we cover how to write it up in audit and closing the loop. A QI project is strong evidence presented as QI, covered in quality improvement projects. If one of those projects was also published, that publication is a bonus that sits in your research evidence, described accurately as "a published audit", not as a research study.

Authorship integrity: are you really an author?

When research does feature in a portfolio, the question assessors ask is not only "is this published?" but "what did this doctor actually do?" The international standard for answering that is the International Committee of Medical Journal Editors (ICMJE) definition of authorship, which most reputable journals require. It sets four criteria, and a named author is meant to meet all four.

Two things follow that are worth taking seriously. First, contributions that do not meet all four criteria, such as funding acquisition, general supervision of a department, or providing data alone, do not by themselves justify authorship under ICMJE; they belong in the acknowledgements. The Committee on Publication Ethics (COPE) takes the same line and warns specifically against gift, guest and ghost authorship. If your name is on a paper you had little real involvement in, that is not the asset it looks like, and you should not build your portfolio narrative on it.

Second, the inverse is the good news. You do not need to be first author on everything. A middle-author role on a sound multi-centre study, described precisely and backed by the paper's contributorship statement, is honest and persuasive evidence. The strongest thing you can add to any listed publication is a short note of your own that maps what you did onto the four criteria above. It shows integrity, and integrity is itself part of the GMC domains being assessed.

The predatory journal trap

This section matters most for internationally trained doctors, though it catches UK applicants too. Predatory journals charge a publication fee and publish with little or no genuine peer review. They often have plausible-sounding names, promise rapid publication, and email unsolicited invitations to submit. A paper in one of them is not neutral on a portfolio. It can actively weaken it, because it signals either a lapse in judgement or an attempt to inflate the record, and it invites the assessor to look harder at everything else.

The honest reality is that the pressure to publish, combined with aggressive solicitation, means many good doctors have a predatory-journal paper somewhere in their history. If you do, the pragmatic move is usually to leave it out rather than feature it. Lead with the genuine peer-reviewed and disseminated work, however modest, and let the predatory item stay off the page.

Checking a journal before you rely on it is quick. Confirm it is indexed in a recognised database such as MEDLINE, PubMed Central, the Directory of Open Access Journals or Scopus. Check whether it follows the principles of transparency and best practice set out jointly by COPE, the DOAJ, the Open Access Scholarly Publishing Association and the World Association of Medical Editors. Look at whether the editorial board is real and contactable and whether the peer-review process is described honestly. If a journal cannot pass those checks, it will not help your application.

Turning one paper into portfolio-ready evidence

A bare citation is the weakest possible way to present research. The portfolio is assessed on documentary evidence only, so the assessor can only credit what they can see. The goal is to turn each item into a small, self-contained, easy-to-verify package that maps to a capability and shows your contribution. Here is the sequence that works for a single publication.

The reflection in move four is what lifts research from a line on a list to genuine evidence of a capability. It does not need to be long. A few honest sentences on what the work taught you, how it changed your practice or your department's, and what you would do differently next time is enough. The discipline is the same one we describe in reflective practice writing: specific, honest, and short enough to survive a panel reading it carefully.

Do the same for each item, then index them. Assessors give weight to portfolios that are easy to navigate, with every piece of evidence tagged to the capability it supports. A small set of well-packaged publications, each mapped and reflected on, beats a long reference list with nothing behind it. This is the same logic that runs through the whole application, set out in the Capabilities in Practice guide.

Mapping research to the GMC domains

Research evidence is more versatile than it first appears. It naturally lands in domain one, but a well-chosen item can speak to all four domains of Good Medical Practice 2024. Showing that range is part of presenting it well.

You do not need every paper to hit every domain. The useful habit is to ask, for each research item, which domain it best evidences and to tag it there, rather than letting it all pile up under domain one. A single study that recruited patients, improved a pathway, and was conducted with clean governance can legitimately be cited against three domains, with a sentence each explaining how. That kind of mapping is what assessors mean when they ask for evidence that is organised rather than merely present.

Recency and the five-year rule

The GMC expects the bulk of a portfolio to come from the last five years. Research is not exempt. A strong publication record that stops eight years ago tells an assessor about who you were, not who you are now. Older work is still accepted in support, particularly where it shows breadth or a sustained track record over a career, but it should not be carrying the application on its own.

If your research output is genuinely historic, the fix is not to manufacture a paper. It is to show that scholarly engagement is ongoing through activity that is easier to generate than original research: take on journal peer review, contribute to a current departmental project, run a journal club, or write up and publish a recent audit. Any of these demonstrates that your engagement with the evidence base is live, which is what the recency expectation is really testing. We go deeper on this in the dedicated guide to the five-year rule and recent evidence.

If you have no publications at all

This is more common than the literature-heavy framing of the route suggests, and it is not the barrier doctors fear. Many successful Portfolio Pathway applicants reach the Specialist Register without a single peer-reviewed paper, because their clinical, governance and educational evidence is strong and their SSG does not demand publications. If that is you, do three things rather than panic.

The associate or site investigator route deserves a special mention because it is the most realistic on-ramp for a busy clinician. Schemes such as the National Institute for Health and Care Research associate principal investigator scheme let you contribute to delivering a portfolio study, recruiting patients and learning the governance, with a recognised record at the end. It is research engagement without needing to design and lead a study from scratch, and it generates exactly the kind of recent, verifiable evidence the pathway values.

How research expectations vary by specialty

There is no single rule across the colleges, which is why the SSG always wins over any general guidance, ours included. Some academic-leaning specialties expect to see more scholarly activity; others are satisfied by engagement with the evidence base and place almost all the weight on clinical and procedural evidence. Read your specialty's overview and its SSG together before you decide how much research effort the application actually needs.

A note for internationally trained applicants specifically. An overseas research record counts, and many of the strongest applicants bring one. Present it with the journal's standing made clear, provide certified translations where needed, and be alert to the predatory-journal issue, which is more aggressively marketed in some regions than others. Where overseas evidence needs framing for a UK assessor, the guide to translating overseas evidence covers the practicalities.

Where this sits in the evidence cluster

Research is one strand among the evidence types that together populate the four GMC domains. Build it in parallel with the others rather than treating it as a separate project, and read it alongside the cluster below.

Frequently asked questions

Do I need publications to get on the Specialist Register via the Portfolio Pathway?

For most specialties, no. The standard Portfolio Pathway is built on clinical evidence: case logs, workplace-based assessments, audit, multi-source feedback, teaching and structured reports. Research and publications are supporting evidence that strengthen an application, not a mandatory gate. Always check your specialty's GMC Specialty Specific Guidance for the exact wording, because expectations differ by college. The route where research is the core requirement is the separate academic or research route, not the standard pathway.

What is the difference between the Portfolio Pathway and the academic or research route?

They are different applications. The standard Portfolio Pathway asks you to demonstrate the knowledge, skills and experience of a UK consultant, with research as one supporting strand. The academic or research route is for doctors whose career is research-led: the GMC expects you to show you are at least a nationally renowned leader in your field and known internationally, with research published in high-impact peer-reviewed journals. Most clinically focused applicants use the standard pathway, not the academic route.

Does a published audit or a conference poster count as research evidence?

Yes, but present it honestly as what it is. A published audit is audit evidence that also shows scholarly output. A conference poster or oral presentation is dissemination evidence. Both count and both are worth including. What weakens an application is relabelling audit or service evaluation as research, or listing a poster as if it were a peer-reviewed paper. Describe each item accurately, name your specific contribution, and let it count in the right category.

Do overseas publications count for the Portfolio Pathway?

Yes. Research published outside the UK counts, and many strong applicants bring an international publication record. Provide the full text, an English translation where needed, and clear evidence of the journal's standing and peer-review process. The one real trap is predatory or pay-to-publish journals, which add no weight and can undermine the rest of the portfolio. Check each journal against recognised indexing and the principles of transparency before you rely on it as evidence.

I am a middle author on several papers. How do I evidence my contribution?

Provide the contributorship or author-contribution statement from the paper, and add a short note of your own describing exactly what you did, mapped to the four ICMJE authorship criteria. Assessors are not looking for first authorship on everything. They want honest, specific evidence of a real intellectual contribution. A clearly described middle-author role on a sound study is stronger than a vague claim of first authorship you cannot substantiate.

How recent does my research evidence need to be?

The GMC expects the bulk of a portfolio to come from the last five years. Older publications are accepted in support, particularly where they show breadth or a sustained track record, but they should not carry the application on their own. A paper from a decade ago is fine as part of the picture. If your only research output is old, pair it with recent scholarly activity such as journal peer review, a current project, or a published audit to show the engagement is ongoing.